Viewing Study NCT02753894

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-02-09 @ 2:13 AM
Study NCT ID: NCT02753894
Status: COMPLETED
Last Update Posted: 2016-06-21
First Post: 2016-03-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose-finding View
None Hemodialysis View
None ASP1585 View
None Chronic kidney disease View